VEGF pathway inhibitor (Eleven Biotherapeutics)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameVEGF pathway inhibitor (Eleven Biotherapeutics)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionVascular endothelial growth factor receptor antagonists

TargetsVascular endothelial growth factor receptor

Therapy Area/IndicationsDiabetic macular oedemaWet age-related macular degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSesen Bio Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSesen Bio Inc

Active IndicationsN/A

Inactive IndicationsDiabetic macular oedemaWet age-related macular degeneration

ATC CodeN/A